Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article



Design, Synthesis and In-Silico Studies of Novel Chalcones as Anti-Prostate Cancer and Cathepsin B Inhibitors

Dalia Hussein Soliman; Amel Mostafa Farrag; Ola Omran.

Abstract
The high mortality rate in prostate cancer patients could be mainly attributed to the invasiveness and metastasis of advanced prostate cancer. Cathepsin B, a lysosomal cysteine, that proved to play a significant role in the invasion and metastasis of prostate cancer, therefore, the search for selective cathepsin B inhibitors could be considered an active area of research. Chalcones have proved to be effective anticancer agents against most human malignancies, they have also been reported to exhibit significant cathepsin B inhibition. In the present study, a series of novel N-(4-3-(pheny)-1-prop-2-en-1-one phenyl)benzamide derivatives (5a-p) were synthesized, characterized and evaluated for their anti-prostate cancer activities against PC-3 prostate adenocarcinoma cell line using the SRB method. The cathepsin B inhibition potential was further tested by the using enzyme-linked immunosorbent assay. Moreover, a pharmacophore model was constructed, a QSAR study was carried out where a model was successfully built from which the physicochemical parameters were correlated to the activity. Furthermore, molecular docking studies were also carried out to determine the binding mode of the active compounds into the active site of Cathepsin B enzyme. The furyl derivative 5p was the most active candidate, (IC50 = 5.597 μΜ), against prostate cancer cell line, PC-3. This derivative also demonstrated 50.4% reduction in concentration of cathepsin B, additionally, compounds 5b and 5m showed 53.2 and 56.6% reduction in concentration of cathepsin B, respectively. In conclusion, compounds 5b, 5m and 5p showed good activity both as antiproliferative and as inhibitors of Cathepsin B production. The developed QSAR model was found statistically significant and has good predictive power. Docking studies of the active derivatives maintained the essential key interactions, specially with the cysteine residue, Cys29.

Key words: prostate cancer;cathepsin B;chalcones



Share this Article


Advertisement
Archives of Clinical and Experimental Surgery (ACES)

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons